Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Kidney (Renal) Fibrosis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Kidney (Renal) Fibrosismarket, defines the market attractiveness level of Kidney (Renal) Fibrosis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Kidney (Renal) Fibrosis industry, describes the types of Kidney (Renal) Fibrosis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Kidney (Renal) Fibrosis market and the development prospects and opportunities of Kidney (Renal) Fibrosis industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Kidney (Renal) Fibrosis market in Chapter 13.
By Player:
Galectin Therapeutics
BioLine Rx Ltd
Roche
InterMune
ProMetic Life-Sciences Inc
Pfizer
Merck
Genzyme Corporation
La Jolla Pharmaceutical Company
By Type:
Angiotensin Converting enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
By End-User:
Research Center
Hospital
Clinic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Kidney (Renal) Fibrosis Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Kidney (Renal) Fibrosis Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Kidney (Renal) Fibrosis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Kidney (Renal) Fibrosis Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Kidney (Renal) Fibrosis Market Analysis and Outlook to 2022
-
7.1 Global Kidney (Renal) Fibrosis Consumption (2017-2022)
-
7.2 United States Kidney (Renal) Fibrosis Consumption (2017-2022)
-
7.3 Europe Kidney (Renal) Fibrosis Consumption (2017-2022)
-
7.4 China Kidney (Renal) Fibrosis Consumption (2017-2022)
-
7.5 Japan Kidney (Renal) Fibrosis Consumption (2017-2022)
-
7.6 India Kidney (Renal) Fibrosis Consumption (2017-2022)
-
7.7 South Korea Kidney (Renal) Fibrosis Consumption (2017-2022)
8 Region and Country-wise Kidney (Renal) Fibrosis Market Analysis and Outlook to 2028
-
8.1 Global Kidney (Renal) Fibrosis Consumption Forecast (2022-2028)
-
8.2 United States Kidney (Renal) Fibrosis Consumption Forecast (2022-2028)
-
8.3 Europe Kidney (Renal) Fibrosis Consumption Forecast (2022-2028)
-
8.4 China Kidney (Renal) Fibrosis Consumption Forecast (2022-2028)
-
8.5 Japan Kidney (Renal) Fibrosis Consumption Forecast (2022-2028)
-
8.6 India Kidney (Renal) Fibrosis Consumption Forecast (2022-2028)
-
8.7 South Korea Kidney (Renal) Fibrosis Consumption Forecast (2022-2028)
9 Global Kidney (Renal) Fibrosis Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney (Renal) Fibrosis Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Angiotensin Converting enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pirfenidone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Renin Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Angiotensin II Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Vasopeptidase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney (Renal) Fibrosis Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Research Center Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)
10 Global Kidney (Renal) Fibrosis Market Outlook by Types and Applications to 2028
-
10.1 Global Kidney (Renal) Fibrosis Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Angiotensin Converting enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Renin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Angiotensin II Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Vasopeptidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Kidney (Renal) Fibrosis Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
11 Global Kidney (Renal) Fibrosis Import and Export Analysis (Top 5 Countries)
-
11.1 Global Kidney (Renal) Fibrosis Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Kidney (Renal) Fibrosis Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Kidney (Renal) Fibrosis Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Kidney (Renal) Fibrosis Market Competitive Analysis
-
14.1 Galectin Therapeutics
-
14.1.1 Galectin Therapeutics Company Details
-
14.1.2 Galectin Therapeutics Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Galectin Therapeutics Kidney (Renal) Fibrosis Product and Service
-
14.2 BioLine Rx Ltd
-
14.2.1 BioLine Rx Ltd Company Details
-
14.2.2 BioLine Rx Ltd Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Kidney (Renal) Fibrosis Product and Service
-
14.4 InterMune
-
14.4.1 InterMune Company Details
-
14.4.2 InterMune Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 InterMune Kidney (Renal) Fibrosis Product and Service
-
14.5 ProMetic Life-Sciences Inc
-
14.5.1 ProMetic Life-Sciences Inc Company Details
-
14.5.2 ProMetic Life-Sciences Inc Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 ProMetic Life-Sciences Inc Kidney (Renal) Fibrosis Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Kidney (Renal) Fibrosis Product and Service
-
14.7 Merck
-
14.7.1 Merck Company Details
-
14.7.2 Merck Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck Kidney (Renal) Fibrosis Product and Service
-
14.8 Genzyme Corporation
-
14.8.1 Genzyme Corporation Company Details
-
14.8.2 Genzyme Corporation Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Genzyme Corporation Kidney (Renal) Fibrosis Product and Service
-
14.9 La Jolla Pharmaceutical Company
-
14.9.1 La Jolla Pharmaceutical Company Company Details
-
14.9.2 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Kidney (Renal) Fibrosis
-
Figure Kidney (Renal) Fibrosis Picture
-
Table Global Kidney (Renal) Fibrosis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney (Renal) Fibrosis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney (Renal) Fibrosis Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Kidney (Renal) Fibrosis Consumption by Country (2017-2022)
-
Figure United States Kidney (Renal) Fibrosis Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney (Renal) Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure China Kidney (Renal) Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney (Renal) Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure India Kidney (Renal) Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney (Renal) Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney (Renal) Fibrosis Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney (Renal) Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney (Renal) Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Kidney (Renal) Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney (Renal) Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney (Renal) Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney (Renal) Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiotensin Converting enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Pirfenidone Consumption and Growth Rate (2017-2022)
-
Figure Global Renin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin II Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)
-
Figure Global Vasopeptidase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin Converting enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiotensin II Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vasopeptidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Kidney (Renal) Fibrosis Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Kidney (Renal) Fibrosis Export by Region (Top 5 Countries) (2017-2028)
-
Table Galectin Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Galectin Therapeutics Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galectin Therapeutics Kidney (Renal) Fibrosis Product and Service
-
Table BioLine Rx Ltd (Foundation Year, Company Profile and etc.)
-
Table BioLine Rx Ltd Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioLine Rx Ltd Kidney (Renal) Fibrosis Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Kidney (Renal) Fibrosis Product and Service
-
Table InterMune (Foundation Year, Company Profile and etc.)
-
Table InterMune Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table InterMune Kidney (Renal) Fibrosis Product and Service
-
Table ProMetic Life-Sciences Inc (Foundation Year, Company Profile and etc.)
-
Table ProMetic Life-Sciences Inc Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProMetic Life-Sciences Inc Kidney (Renal) Fibrosis Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Kidney (Renal) Fibrosis Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Kidney (Renal) Fibrosis Product and Service
-
Table Genzyme Corporation (Foundation Year, Company Profile and etc.)
-
Table Genzyme Corporation Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Corporation Kidney (Renal) Fibrosis Product and Service
-
Table La Jolla Pharmaceutical Company (Foundation Year, Company Profile and etc.)
-
Table La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product and Service
-
